About a third of lung transplant patients with cystic fibrosis receive elexacaftor-tezacaftor-ivacaftor; use is higher among ...

Vertex Pharmaceuticals today announced that Health Canada has granted Marketing Authorization for PrALYFTREKTM (vanzacaftor/tezacaftor/deutivacaftor), a new triple combination therapy for patients ...

‘On the Record’: Combating cystic fibrosis ...

The guidance updates a list of conditions that disqualify potential recruits from serving in the armed forces.

Today, the Cystic Fibrosis Foundation announced an additional investment of up to $24 million in Prime Medicine to continue ...

The Pentagon has issued new rules that would prevent people currently treated for schizophrenia, congestive heart failure, ...

NHS patients in England with cystic fibrosis will be among the first in Europe to access a new treatment for their condition, ...

The Cystic Fibrosis Foundation has agreed to provide Prime Medicine Inc. an additional investment of up to $24 million to ...

A new once daily triple drug treatment for cystic fibrosis is set to be “immediately funded” by NHS England following recommendation from the National Institute for Health and Care Excellence (NICE).1 ...

Saturday is 'National Ice Cream Day' and one Granger ice cream shop is going the extra scoop for this sweet event!The Chief ...

Axtell spent 15 hours paddleboarding the gap between Bimini and Lake Worth Beach. Although stormy and hot weather made it ...

Vertex Pharmaceuticals (VRTX) announced that Health Canada has granted Marketing Authorization for ALYFTREK, a new triple combination therapy for ...